Arkolith/Insider Trading/TMDX/Form 4

Hassanein Waleed H

President & CEO, DirectorTransMedics Group, Inc. (TMDX) · full profile →Form 4 · filed Oct 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2024Sell(S)300$135.04$41K62K
Oct 15, 2024Sell(S)1K$134.23$161K62K
Oct 15, 2024Option exercise(M)9K$13.28$115K70K
Oct 15, 2024Sell(S)4K$131.91$476K67K
Oct 15, 2024Sell(S)4K$132.82$467K63K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 15, 2024Option exercise(M)9K—$096K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-115332) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for TransMedics Group, Inc.

Build

Ask your agent about TMDX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000950170-24-115332"
Ask your agent
Use Arkolith to summarize insider buying and selling at TransMedics Group, Inc.
over the last 90 days and cite the filings.